Update in postinfectious bronchiolitis obliterans.
adenovirus
chronic obstructive pulmonary disease
respiratory failure
Journal
Pediatric pulmonology
ISSN: 1099-0496
Titre abrégé: Pediatr Pulmonol
Pays: United States
ID NLM: 8510590
Informations de publication
Date de publication:
28 Jun 2023
28 Jun 2023
Historique:
revised:
16
05
2023
received:
15
12
2022
accepted:
15
06
2023
medline:
28
6
2023
pubmed:
28
6
2023
entrez:
28
6
2023
Statut:
aheadofprint
Résumé
Postinfectious bronchiolitis obliterans (PiBO) is a rare and severe form of chronic obstructive lung disease caused by an infectious injury to the lower respiratory tract. The most commonly recognized inciting stimuli leading to PiBO are airway pathogens, such as adenovirus and Mycoplasma. PiBO is characterized by persistent and nonreversible airway obstruction, with functional and radiological evidence of small airway involvement. The literature has limited information on the aetiology, clinical profile, treatment, and outcome of PiBO.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : None
Informations de copyright
© 2023 Wiley Periodicals LLC.
Références
Hardy KA, Schidlow DV, Zaeri N. Obliterative bronchiolitis in children. Chest. 1988;93(3):460-466.
Mauad T, Dolhnikoff M. Histology of childhood bronchiolitis obliterans. Pediatr Pulmonol. 2002;33(6):466-474.
Boehler A, Estenne M. Post-transplant bronchiolitis obliterans. Eur Respir J Monogr. 2003;26:158-178.
Jaramillo A, Fernández FG, Kuo EY, Trulock EP, Patterson GA, Mohanakumar T. Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation. Pediatr Tranplant. 2005;9(1):84-93.
Colom AJ. Risk factors for the development of bronchiolitis obliterans in children with bronchiolitis. Thorax. 2006;61:503-506.
Murtagh P, Giubergia V, Viale D, Bauer G, Pena HG. Lower respiratory infections by adenovirus in children. Clinical features and risk factors for bronchiolitis obliterans and mortality. Pediatr Pulmonol. 2009;44(5):450-456.
Zhang L, Irion K, Kozakewich H, et al. Clinical course of postinfectious bronchiolitis obliterans. Pediatr Pulmonol. 2000;29:341-350.
Castro-Rodriguez JA, Daszenies C, Garcia M, Meyer R, Gonzales R. Adenovirus pneumonia in infants and factors for developing bronchiolitis obliterans: a 5-year follow-up. Pediatr Pulmonol. 2006;41:947-953.
Yalçın E, Doğru D, Haliloğlu M, Özçelik U, Kiper N, Göçmen A. Postinfectious bronchiolitis obliterans in children: clinical and radiological profile and prognostic factors. Respiration. 2003;70:371-375.
Chang AB, Masel JP, Masters B. Post-infectious bronchiolitis obliterans: clinical, radiological and pulmonary function sequelae. Pediatr Radiol. 1998;28:23-29.
Becroft DMO. Bronchiolitis obliterans, bronchiectasis, and other sequelae of adenovirus type 21 infection in young children. J Clin Pathol. 1971;24:72-82.
Krasinski K. Severe respiratory syncytial virus infection: clinical features, nosocomial acquisition and outcome. Pediatr Infect Dis J. 1985;4:250-257.
Welliver RC. Parainfluenza virus bronchiolitis. Am J Dis Child. 1986;140:34-40.
Laraya-Cuasay LR, DeForest A, Huff D, Lischner H, Huang NN. Chronic pulmonary complications of early influenza virus infection in children. Am Rev Respir Dis. 1977;116:617-625.
Similä S, Linna O, Lanning P, Heikkinen E, Ala-Houhala M. Chronic lung damage caused by adenovirus type 7: a ten year follow up study. Chest. 1981;80:127-131.
Wiebicke W, Seidenberg J. Obliterating bronchiolitis following measles. Pneumologie. 1990;44(10):1220-1222.
Sato P, Madtes DK, Thorning D, Albert RK. Bronchiolitis obliterans caused by Legionella pneumophila. Chest. 1985;87:840-842.
Trimis G, Theodoridou M, Mostrou G, Kakavakis K. Swyer-James (MacLeod's) syndrome following pertussis infection in an infant. Scand J Infect Dis. 2003;35:197-199.
Díaz F, Collazos J, Martinez E, Mayo J. Bronchiolitis obliterans in a patient with HIV infection. Respir Med. 1997;91:171-173.
Bryan C. Diseases characterized by airflow limitation. In: Bryan C, ed. Pathology of the Lungs. Churchill Livingstone/Hartcourt Publishers, Ltd; 2000:79-120.
Myers JL, Colby TV. Pathologic manifestations of bronchiolitis, constrictive bronchiolitis, cryptogenic organizing pneumonia and diffuse panbronchiolitis. Clin Chest Med. 1993;14:611-622.
Schlesinger C, Meyer CA, Veeraraghavan S, Koss MN. Constrictive (obliterative) bronchiolitis: diagnosis, etiology, and a critical review of the literature. Ann Diagn Pathol. 1998;2:321-334.
Cazzato S, Poletti V, Bernardi F, et al. Airway inflammation and lung function decline in childhood post-infectious bronchiolitis obliterans. Pediatr Pulmonol. 2008;43(4):381-390.
Jerkic SP, Koc-Günel S, Herrmann E, et al. Long-term course of bronchial inflammation and pulmonary function testing in children with postinfectious bronchiolitis obliterans. Pediatr Pulmonol. 2021;56(9):2966-2972.
Eckrich J, Herrmann E, Voss S, Schubert R, Zielen S, Rosewich M. Short-term variation of lung function and airway inflammation in children and adolescents with bronchiolitis obliterans. Lung. 2016;194(4):571-579.
Jerkic SP, Michel F, Donath H, et al. Calprotectin as a new sensitive marker of neutrophilic inflammation in patients with bronchiolitis obliterans. Mediators Inflamm. 2020;2020:1-7.
Rosewich M, Zissler UM, Kheiri T, et al. Airway inflammation in children and adolescents with bronchiolitis obliterans. Cytokine. 2015;73(1):156-162.
Naqvi RA, Gupta M, George A, Naqvi AR. MicroRNAs in shaping the resolution phase of inflammation. Semin Cell Dev Biol. 2022;124:48-62.
Liu Y, Li H, Xiao T, Lu Q. Epigenetics in immune-mediated pulmonary diseases. Clin Rev Allergy Immunol. 2013;45:314-330.
Kabesch M, Adcock IM. Epigenetics in asthma and COPD. Biochimie. 2012;94:2231-2241.
Cai Y, Yu X, Hu S, Yu J. A brief review on the mechanisms of miRNA regulation. Genom Insights. 2009;7:147-154.
Alipoor SD, Adcock IM, Garssen J, et al. The roles of miRNAs as potential biomarkers in lung diseases. Eur J Pharmacol. 2016;791:395-404.
Duecker RP, De Mir Messa I, Jerkic SP, et al. Epigenetic regulation of inflammation by microRNAs in post-infectious bronchiolitis obliterans. Clin Transl Immunol. 2022;11(2):e1376.
Kang MJ, Ahn HS, Lee SY, Yeom J, Kim K, Hong SJ. TGFβ1 and POSTN as biomarkers of postinfectious bronchiolitis obliterans and asthma in children. Pediatr Pulmonol. 2022;57(12):3161-3164. doi:10.1002/ppul.26139
Avci E, Sarvari P, Savai R, Seeger W, Pullamsetti SS. Epigenetic mechanisms in parenchymal lung diseases: bystanders or therapeutic targets? Int J Mol Sci. 2022;23:546.
Yeşilbaş O, Şevketoğlu E, Kihtir HS, et al. İnsan metapnömovirus bronşiyolitine ikincil gelişen bronşiyolitis obliterans olgusu. Mikrobiyol Nul. 2016;50(4):606-612.
Zhao C, Liu J, Yang H, Xiang L, Zhao S. Mycoplasma pneumoniae-associated bronchiolitis obliterans following acute bronchiolitis. Sci Rep. 2017;7(1):8478.
Koh YY, Jung DE, Koh JY, Kim JY, Yoo Y, Kim CK. Bronchoalveolar cellularity and interleukin 8 levels in measles bronchiolitis obliterans. Chest. 2007;131(5):1454-1460.
Lee M, Hwang JY, Park SE, Jung S, Jo KJ. A case report of postinfectious bronchiolitis obliterans after coronavirus disease 2019 in a 10-year-old child. J Korean Med Sci. 2022;37(31):e246. doi:10.3346/jkms.2022.37.e246
Kajon AE, Mistchenko AS, Videla C, Hortal M, Wadell G, Avendaño LF. Molecular epidemiology of adenovirus acute lower respiratory infections of children in the South Cone of South America (1991-1994). J Med Virol. 1996;48(2):151-156.
Mistchenko AS, Diez RA, Mariani AL, et al. Cytokines in adenoviral disease in children: association of interleukin-6, interleukin-8, and tumor necrosis factor alpha levels with clinical outcome. J Pediatr. 1994;124(5 Pt 1):714-720.
Lang WR, Howden CW, Laws J, Burton JF. Bronchopneumonia with serious sequelae in children with evidence of adenovirus type 21 infection. BMJ. 1969;1:73-79.
Wenman WM, Pagtakhan RD, Reed MH, Chernick V, Albritton W. Adenovirus bronchiolitis in manitoba. Chest. 1982;81:605-609.
Teper AM, Marcos CY, Theiler G, et al. Association between HLA and the incidence of bronchiolitis obliterans (BO) in Argentina. Am J Respir Crit Care Med. 2004;169:382.
Teper A, Colom A, Bailliet G, et al. Association between the incidence of bronchiolitis obliterans (BO) in Argentine children and their Native-American maternal and paternal lineage. Am J Respir Crit Care Med. 2003;167:998.
Kajon AE, Gigliotti AP, Harrod KS. Acute inflammatory response and remodeling of airway epithelium after subspecies B1 human adenovirus infection of the mouse lower respiratory tract. J Med Virol. 2003;71:233-244.
Leong MA, Nachajon R, Ruchelli E, Allen JL. Bronchitis obliterans due toMycoplasma pneumonia. Pediatr Pulmonol. 1997;23:375-381.
Jerkic SP, Brinkmann F, Calder A, et al. Postinfectious bronchiolitis obliterans in children: diagnostic workup and therapeutic options: a workshop report. Can Respir J. 2020;2020:1-16.
Kurland G, Michelson P. Bronchiolitis obliterans in children. Pediatr Pulmonol. 2005;39(3):193-208.
Swyer PR, James GCW. A case of unilateral pulmonary emphysema. Thorax. 1953;8:133-136.
MacLeod WM. Abnormal transradiancy of one lung. Thorax. 1954;9:147-153.
Leung AN, Fisher K, Valentine V, et al. Bronchiolitis obliterans after lung transplantation. Chest. 1998;113:365-370.
Choi SJ, Choi BK, Kim H, et al. Lateral decubitus HRCT: a simple technique to replace expiratory CT in children with air trapping. Pediatr Radiol. 2002;32:179-182.
Chen IC, Hsu JS, Chen YW, et al. Post-infectious bronchiolitis obliterans: HRCT, DECT, pulmonary scintigraphy images, and clinical follow-up in eight children. Front Pediatr. 2020;8:622065. doi:10.3389/fped.2020.622065
Cheng G-S, Selwa KE, Hatt C, et al. Multicenter evaluation of parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. Am J Transplant (AJT). 2020;20(8):2198-2205. doi:10.1111/ajt.15814
Colom AJ, Maffey A, Garcia Bournissen F, Teper A. Pulmonary function of a paediatric cohort of patients with postinfectious bronchiolitis obliterans. A long term follow-up. Thorax. 2015;70(2):169-174.
Aguerre V, Castaños C, Pena HG, Grenoville M, Murtagh P. Postinfectious bronchiolitis obliterans in children: clinical and pulmonary function findings. Pediatr Pulmonol. 2010;45(12):1180-1185.
Mattiello R, Mallol J, Fischer GB, Mocelin HT, Rueda B, Sarria EE. Função pulmonar de crianças e adolescentes com bronquiolite obliterante pós-infecciosa. J Bras Pneumol. 2010;36(4):453-459.
Teper AM, Kofman CD, Maffey AF, Vidaurreta SM. Lung function in infants with chronic pulmonary disease after severe adenoviral illness. J Pediatr. 1999;134:730-733.
Maffey A, Colom A, Kofman C, et al. Longitudinal study of pulmonary function in infants with postviral chronic pulmonary disease (PCPD). Am J Respir Crit Care Med. 1996;153:498.
Onay ZR, Ramasli Gursoy T, Aslan AT, et al. Postinfectious bronchiolitis obliterans masked by misdiagnosis as asthma. Pediatr Pulmonol. 2020;55(4):1007-1011.
Owens CM, Aurora P, Stanojevic S, et al. Lung clearance index and HRCT are complementary markers of lung abnormalities in young children with CF. Thorax. 2011;66(6):481-488.
Kim YH, Shin HJ, Sol IS, et al. Lung clearance index and quantitative computed tomography of post-infectious bronchiolitis obliterans in infants. Sci Rep. 2017;7(1):15128.
Colom AJ, Teper AM. Clinical prediction rule to diagnose post-infectious bronchiolitis obliterans in children. Pediatr Pulmonol. 2009;44(11):1065-1069. doi:10.1002/ppul.21080
Mosquera RA, Hashmi SS, Pacheco SE, Reverdin A, Chevallier J, Colasurdo GN. Dysanaptic growth of lung and airway in children with post-infectious bronchiolitis obliterans. Eur Clin Respir J. 2014;8(1):63-71.
Narayanan M, Beardsmore CS, Owers-Bradley J, et al. Catch-up alveolarization in ex-preterm children. evidence from 3He magnetic resonance. Am J Respir Crit Care Med. 2013;187:1104-1109.
Narayanan M, Owers-Bradley J, Beardsmore CS, et al. Alveolarization continues during childhood and adolescence: new evidence from helium-3 magnetic resonance. Am J Respir Crit Care Med. 2012;185:186-191.
Tanou K, Xaidara A, Kaditis AG. Efficacy of pulse methylprednisolone in a pediatric case of postinfectious bronchiolitis obliterans. Pediatr Pulmonol. 2015;50(5): E13-E16.
Kerger BD, Fedoruk MJ. Pathology, toxicology, and latency of irritant gases known to cause bronchiolitis obliterans disease: does diacetyl fit the pattern? Toxicol Rep. 2015;2:1463-1472.
Tomikawa SO, Adde FV, da Silva Filho LVRF, Leone C, Rodrigues JC. Follow-up on pediatric patients with bronchiolitis obliterans treated with corticosteroid pulse therapy. Orphanet J Rare Dis. 2014;9(1):128.
Wang X, Liu C, Wang M, Zhang Y, Li H, Liu G. Clinical features of post-infectious bronchiolitis obliterans in children undergoing long-term azithromycin treatment. Exp Ther Med. 2015;9(6):2379-2383.
Corris PA, Ryan VA, Small T, et al. A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation. Thorax. 2015;70(5):442-450.
Verleden GM, Verleden SE, Vos R, et al. Montelukast for bronchiolitis obliterans syndrome after lung transplantation: a pilot study. Transpl Int. 2011;24(7):651-656.
Williams KM, Cheng GS, Pusic I, et al. Fluticasone, azithromycin, and montelukast. treatment for new-onset bronchiolitis obliterans syndrome after hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2016;22(4):710-716.
Colom AJ, Teper AM. Post-infectious bronchiolitis obliterans. Pediatr Pulmonol. 2019;54(2):212-219.